Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $735.92 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $339.47 | 3 | $0 (2018) |
| Amgen Inc. | $127.31 | 2 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $123.46 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $105.99 | 1 | $0 (2020) |
| PFIZER INC. | $39.69 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $105.99 | 1 | AstraZeneca Pharmaceuticals LP ($105.99) |
| 2019 | $103.24 | 1 | Amgen Inc. ($103.24) |
| 2018 | $269.77 | 4 | PORTOLA PHARMACEUTICALS, INC. ($123.46) |
| 2017 | $256.92 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($230.72) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/20/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $105.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $103.24 | General |
| Category: Cardiology | ||||||
| 12/06/2018 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Cardiology | ||||||
| 07/18/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | In-kind items and services | $123.46 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
| 03/03/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/06/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $108.75 | General |
| Category: DIABETES | ||||||
| 12/05/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 09/01/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/14/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/02/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $105.72 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 332 | 469 | $119,715 | $37,421 |
| 2022 | 4 | 282 | 415 | $96,065 | $28,557 |
| 2021 | 7 | 490 | 940 | $189,312 | $68,601 |
| 2020 | 7 | 568 | 1,120 | $265,370 | $84,478 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 104 | 160 | $42,134 | $14,929 | 35.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 132 | 212 | $36,521 | $13,197 | 36.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $21,057 | $3,842 | 18.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 35 | 35 | $5,984 | $2,225 | 37.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 22 | 22 | $7,779 | $1,989 | 25.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 12 | $6,240 | $1,239 | 19.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 137 | 238 | $38,694 | $13,446 | 34.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 77 | 109 | $32,711 | $8,845 | 27.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $17,342 | $3,773 | 21.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 44 | 44 | $7,318 | $2,494 | 34.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 168 | 485 | $80,543 | $28,235 | 35.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 124 | 232 | $49,910 | $19,410 | 38.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 56 | 62 | $28,001 | $9,688 | 34.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 102 | 119 | $18,692 | $6,836 | 36.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 14 | 14 | $5,327 | $2,069 | 38.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 16 | $4,902 | $1,663 | 33.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 11 | 12 | $1,938 | $700.20 | 36.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 196 | 566 | $104,993 | $33,240 | 31.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 126 | 290 | $76,870 | $24,619 | 32.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 65 | 68 | $35,078 | $11,209 | 32.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 102 | 114 | $21,149 | $6,759 | 32.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 38 | 39 | $13,652 | $4,448 | 32.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 19 | 20 | $9,361 | $2,870 | 30.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 22 | 23 | $4,267 | $1,333 | 31.2% |
About Dr. Rory Williams, MD
Dr. Rory Williams, MD is a Family Medicine healthcare provider based in Bartow, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1043522915.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rory Williams, MD has received a total of $735.92 in payments from pharmaceutical and medical device companies, with $105.99 received in 2020. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($735.92).
As a Medicare-enrolled provider, Williams has provided services to 1,672 Medicare beneficiaries, totaling 2,944 services with total Medicare billing of $219,057. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Bartow, FL
- Active Since 07/08/2010
- Last Updated 07/21/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1043522915
Products in Payments
- JARDIANCE (Drug) $214.47
- OFEV (Drug) $125.00
- BEVYXXA (Drug) $123.46
- LOKELMA (Drug) $105.99
- Repatha (Biological) $103.24
- CHANTIX (Drug) $39.69
- Corlanor (Drug) $24.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.